IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.755
NA - Nord America 3.209
AS - Asia 2.602
SA - Sud America 509
AF - Africa 117
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.075
RU - Federazione Russa 1.059
SG - Singapore 795
IE - Irlanda 751
IT - Italia 577
CN - Cina 460
VN - Vietnam 403
BR - Brasile 365
HK - Hong Kong 346
DE - Germania 315
SE - Svezia 293
FR - Francia 195
UA - Ucraina 186
IN - India 140
GB - Regno Unito 98
CA - Canada 85
FI - Finlandia 84
KR - Corea 77
ID - Indonesia 71
BD - Bangladesh 64
AR - Argentina 53
NL - Olanda 42
TR - Turchia 42
MX - Messico 33
BJ - Benin 32
JP - Giappone 32
ZA - Sudafrica 31
IR - Iran 29
IQ - Iraq 28
AT - Austria 27
PK - Pakistan 27
ES - Italia 26
PL - Polonia 26
EC - Ecuador 23
CL - Cile 22
CZ - Repubblica Ceca 22
MY - Malesia 18
AU - Australia 14
TH - Thailandia 13
VE - Venezuela 13
PY - Paraguay 12
PE - Perù 11
TW - Taiwan 10
CH - Svizzera 9
EG - Egitto 9
LT - Lituania 9
KE - Kenya 8
MA - Marocco 8
PH - Filippine 8
BE - Belgio 7
CO - Colombia 7
NG - Nigeria 7
IL - Israele 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
TN - Tunisia 4
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CU - Cuba 2
ET - Etiopia 2
GA - Gabon 2
NO - Norvegia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
PA - Panama 1
PR - Porto Rico 1
Totale 10.204
Salva come PNG Salva come JPEG
Città #
Dublin 739
San Jose 467
Hong Kong 330
Singapore 330
Jacksonville 309
Ashburn 242
Council Bluffs 189
Moscow 136
Beijing 128
Ho Chi Minh City 109
Lauterbourg 105
Chandler 99
Los Angeles 94
Hanoi 86
Lawrence 82
Princeton 82
Wilmington 71
New York 69
San Mateo 69
Columbus 65
Novara 63
Jakarta 55
Dearborn 54
Seoul 53
Munich 52
Piemonte 49
Milan 46
Santa Clara 44
Helsinki 43
Turin 43
Orem 42
Buffalo 41
São Paulo 39
Dong Ket 36
Dallas 35
Frankfurt am Main 34
Chennai 33
Cotonou 32
Montreal 31
Bremen 27
Nuremberg 26
Ann Arbor 25
Vercelli 25
Redondo Beach 24
Toronto 23
Boardman 22
Denver 22
Warsaw 22
Andover 21
Tokyo 21
Brooklyn 20
Amsterdam 19
Brno 19
London 19
Johannesburg 18
Da Nang 17
Falkenstein 17
Mexico City 17
Norwalk 16
Rome 16
Stockholm 16
Vienna 16
Houston 15
Boston 13
Monmouth Junction 13
Poplar 13
Rio de Janeiro 13
Haiphong 12
Hangzhou 12
Istanbul 12
Phoenix 12
Santiago 12
Dhaka 11
Guangzhou 11
Ankara 10
Atlanta 10
Augusta 10
Bologna 10
Kocaeli 10
Mumbai 10
Paris 10
Shanghai 10
Tianjin 10
West Jordan 10
Ardabil 9
Baghdad 9
Chicago 9
Guayaquil 9
The Dalles 9
Alessandria 8
City of London 8
Fairfield 8
Gangbuk-gu 8
Nairobi 8
Nanjing 8
Philadelphia 8
Seattle 8
Turku 8
Asunción 7
Bangkok 7
Totale 5.474
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 385
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 257
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 200
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 181
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 181
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 173
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 169
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 167
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 162
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 161
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 140
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 136
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 135
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 135
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 128
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 128
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 127
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 126
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 126
Chronic hepatitis C is mild in menstruating women 125
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 124
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 121
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 116
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 114
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 113
CYP2E1 autoantibodies in liver diseases 113
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 111
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 110
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 109
Elastography in Liver-Transplanted Patients 108
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 106
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 105
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 105
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 104
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 102
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 102
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 100
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 99
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 98
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 97
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 96
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 95
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 94
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 93
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 93
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 92
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 92
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 92
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 92
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 88
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 86
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 85
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 85
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 84
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 80
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 80
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 80
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 79
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 79
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 79
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 78
Gender and liver fibrosis in chronic hepatitis: the role of iron status 78
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 75
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 75
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 75
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 72
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 72
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 71
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 71
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 70
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 70
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 70
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 69
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 69
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 69
Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis 69
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 68
Do not trivialize the Fibroscan® examination, value its accuracy 68
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 68
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 67
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 67
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 66
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 66
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 65
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 63
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 63
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 62
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 62
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 62
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 62
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 61
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 61
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 61
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 60
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 59
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 59
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 59
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 59
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 57
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 56
Totale 9.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022613 17 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/20251.568 30 25 110 41 56 158 215 177 324 102 67 263
2025/20265.094 203 169 310 685 454 347 781 819 364 502 299 161
Totale 10.412